Evidence map›Paper›PMID 21326950›Full record

ArticleNucleus (Austin, Tex.)

Dosage effect of zero to three functional LBR-genes in vivo and in vitro.

Sophia Gravemann, Nele Schnipper, Hannes Meyer, Amparo Vaya, Malgorzata Jm Nowaczyk, Anna Rajab, Wolf-Karsten Hofmann, Bastian Salewsky, Holger Tönnies, Heidemarie Neitzel and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nucleus (Austin, Tex.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Nuclear mechanics in disease.Annual review of biomedical engineering · 2011
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 7 countries.

Sophia GravemannInstitute of Medical Genetics, Charité University Medicine, Berlin, Germany.
Nele Schnipper
Hannes Meyer
Amparo Vaya
Malgorzata Jm Nowaczyk
Anna Rajab
Wolf-Karsten Hofmann
Bastian Salewsky
Holger Tönnies
Heidemarie Neitzel
Hans H Stassen
Karl Sperling
Katrin Hoffmann
University of Zurich · CHCharité - Universitätsmedizin Berlin · DEHospital Universitari i Politècnic La Fe · ESInstitute for Transfusion Medicine · USInstitute of Human Genetics · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Lamin B receptor (LBR) is a pivotal architectural protein in the nuclear envelope. Mutations in the Lamin B receptor lead to nuclear hyposegmentation (Pelger-Huët anomaly). We have exactly quantified the nuclear lobulation in neutrophils from individuals with 0, 1, 2 and 3 functional copies of the lamin B receptor gene and analyzed the effect of different mutation types. Our data demonstrate that there is a highly significant gene-dosage effect between the gene copy number and the nuclear segmentation index of neutrophils. This finding is paralleled by a dose-dependent increase in LBR protein and staining intensity of the nuclear membrane in corresponding lymphoblastoid cell lines, which demonstrates a significant correlation on the protein level as well. We further show that LBR expression continually increases during granulopoiesis in vitro from human precursor cells with ovoid nuclei to multi-segmented neutrophil nuclei 11 days later, indicating relevance for regular human granulopoiesis. Altogether, LBR is a unique model that will allow the systematic study of gene-dosage effects and of modifying endogeneous and exogeneous factors on granulopoiesis.

Indexed as

Gene DosageCell LineCell NucleusGene Expression RegulationHumansLamin B ReceptorLeukopoiesisMutationNeutrophilsReceptors, Cytoplasmic and NuclearLamin B ReceptorReceptors, Cytoplasmic and Nucleardosage compensationgene-dosage effectgranulopoiesislamin B receptorLBRneutrophilnucleuspelger anomalyPelger-Huët anomaly

Identifiers

PMID21326950
PMCPMC3030694
OpenAlexW1989371089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.